Arcutis Biotherapeutics Statistics
Total Valuation
ARQT has a market cap or net worth of $2.76 billion. The enterprise value is $2.66 billion.
Important Dates
The next estimated earnings date is Tuesday, May 5, 2026, after market close.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
ARQT has 124.03 million shares outstanding. The number of shares has increased by 5.19% in one year.
| Current Share Class | 124.03M |
| Shares Outstanding | 124.03M |
| Shares Change (YoY) | +5.19% |
| Shares Change (QoQ) | +2.07% |
| Owned by Insiders (%) | 1.63% |
| Owned by Institutions (%) | 83.08% |
| Float | 91.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 60.71 |
| PS Ratio | 7.35 |
| Forward PS | 5.69 |
| PB Ratio | 14.51 |
| P/TBV Ratio | 15.83 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 7.07 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.17, with a Debt / Equity ratio of 0.60.
| Current Ratio | 3.17 |
| Quick Ratio | 2.83 |
| Debt / Equity | 0.60 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.01 |
Financial Efficiency
Return on equity (ROE) is -9.30% and return on invested capital (ROIC) is -2.68%.
| Return on Equity (ROE) | -9.30% |
| Return on Assets (ROA) | -1.95% |
| Return on Invested Capital (ROIC) | -2.68% |
| Return on Capital Employed (ROCE) | -4.03% |
| Weighted Average Cost of Capital (WACC) | 13.60% |
| Revenue Per Employee | $1.06M |
| Profits Per Employee | -$45,596 |
| Employee Count | 354 |
| Asset Turnover | 0.96 |
| Inventory Turnover | 1.97 |
Taxes
In the past 12 months, ARQT has paid $1.17 million in taxes.
| Income Tax | 1.17M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +31.04% in the last 52 weeks. The beta is 1.74, so ARQT's price volatility has been higher than the market average.
| Beta (5Y) | 1.74 |
| 52-Week Price Change | +31.04% |
| 50-Day Moving Average | 25.52 |
| 200-Day Moving Average | 21.54 |
| Relative Strength Index (RSI) | 36.44 |
| Average Volume (20 Days) | 1,513,952 |
Short Selling Information
The latest short interest is 15.29 million, so 12.33% of the outstanding shares have been sold short.
| Short Interest | 15.29M |
| Short Previous Month | 16.38M |
| Short % of Shares Out | 12.33% |
| Short % of Float | 16.64% |
| Short Ratio (days to cover) | 11.65 |
Income Statement
In the last 12 months, ARQT had revenue of $376.07 million and -$16.14 million in losses. Loss per share was -$0.13.
| Revenue | 376.07M |
| Gross Profit | 339.38M |
| Operating Income | -12.23M |
| Pretax Income | -14.97M |
| Net Income | -16.14M |
| EBITDA | -7.56M |
| EBIT | -12.23M |
| Loss Per Share | -$0.13 |
Full Income StatementBalance Sheet
The company has $220.98 million in cash and $114.23 million in debt, with a net cash position of $106.76 million or $0.86 per share.
| Cash & Cash Equivalents | 220.98M |
| Total Debt | 114.23M |
| Net Cash | 106.76M |
| Net Cash Per Share | $0.86 |
| Equity (Book Value) | 189.48M |
| Book Value Per Share | 1.54 |
| Working Capital | 281.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$5.63 million and capital expenditures -$686,000, giving a free cash flow of -$6.31 million.
| Operating Cash Flow | -5.63M |
| Capital Expenditures | -686,000 |
| Depreciation & Amortization | 4.67M |
| Net Borrowing | n/a |
| Free Cash Flow | -6.31M |
| FCF Per Share | -$0.05 |
Full Cash Flow StatementMargins
Gross margin is 90.24%, with operating and profit margins of -3.25% and -4.29%.
| Gross Margin | 90.24% |
| Operating Margin | -3.25% |
| Pretax Margin | -3.98% |
| Profit Margin | -4.29% |
| EBITDA Margin | -2.01% |
| EBIT Margin | -3.25% |
| FCF Margin | n/a |
Dividends & Yields
ARQT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.19% |
| Shareholder Yield | -5.19% |
| Earnings Yield | -0.58% |
| FCF Yield | -0.23% |
Analyst Forecast
The average price target for ARQT is $34.00, which is 52.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $34.00 |
| Price Target Difference | 52.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 23.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ARQT has an Altman Z-Score of 3.03 and a Piotroski F-Score of 2.
| Altman Z-Score | 3.03 |
| Piotroski F-Score | 2 |
